Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989751695> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W1989751695 endingPage "67" @default.
- W1989751695 startingPage "64" @default.
- W1989751695 abstract "In this phase II trial 31 patients with advanced gastric cancer (21 with metastatic cancer and 10 with locally advanced cancer) were treated with a continuous 24-hour infusion of 5-fluorouracil (5-FU) 330 mg/m2/day plus low-dose cisplatin (CDDP) 6 mg/m2/day by bolus infusion on days 1–5. The regimen with a combination of 5-FU and low-dose CDDP (FLDP) was repeated weekly for two to four courses according to response and tolerance. In 24 (77%) of the 31 patients, four courses of this regimen were administered. The overall response rate was in 14/31 (45%) patients with measurable disease, including one complete response and 13 partial responses. An especially high response rate of 60% was seen in 10 patients with liver metastasis. Median survival time was 11 months (range 6–27+) in the 10 cases of locally advanced cancer and 11 months (range 6–24+) in the 21 cases of metastatic cancer. Toxicity was primarily hematologic. Leukopenia and thrombocytopenia of World Health Organization (WHO) grade 3 or 4 occurred in 4/31 (13%) and 4/31 (13%) of patients, respectively. Renal dysfunction, which is a major toxicity associated with CDDP, was not observed without hydration. The patients were able to eat during therapy and preserved a good quality of life. A randomized trial including the FLDP regimen is needed to compare it with other active regimens, particularly the use of high-dose CDDP." @default.
- W1989751695 created "2016-06-24" @default.
- W1989751695 creator A5002417935 @default.
- W1989751695 creator A5018146056 @default.
- W1989751695 creator A5031444351 @default.
- W1989751695 creator A5041098371 @default.
- W1989751695 creator A5050788544 @default.
- W1989751695 creator A5057051718 @default.
- W1989751695 creator A5083481852 @default.
- W1989751695 creator A5085579607 @default.
- W1989751695 date "1996-01-01" @default.
- W1989751695 modified "2023-09-29" @default.
- W1989751695 title "Feasibility Study on Protracted Infusional 5-Fluorouracil and Consecutive Low-Dose Cisplatin for Advanced Gastric Cancer" @default.
- W1989751695 doi "https://doi.org/10.1159/000227537" @default.
- W1989751695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8570135" @default.
- W1989751695 hasPublicationYear "1996" @default.
- W1989751695 type Work @default.
- W1989751695 sameAs 1989751695 @default.
- W1989751695 citedByCount "38" @default.
- W1989751695 countsByYear W19897516952012 @default.
- W1989751695 countsByYear W19897516952013 @default.
- W1989751695 countsByYear W19897516952014 @default.
- W1989751695 countsByYear W19897516952023 @default.
- W1989751695 crossrefType "journal-article" @default.
- W1989751695 hasAuthorship W1989751695A5002417935 @default.
- W1989751695 hasAuthorship W1989751695A5018146056 @default.
- W1989751695 hasAuthorship W1989751695A5031444351 @default.
- W1989751695 hasAuthorship W1989751695A5041098371 @default.
- W1989751695 hasAuthorship W1989751695A5050788544 @default.
- W1989751695 hasAuthorship W1989751695A5057051718 @default.
- W1989751695 hasAuthorship W1989751695A5083481852 @default.
- W1989751695 hasAuthorship W1989751695A5085579607 @default.
- W1989751695 hasConcept C121608353 @default.
- W1989751695 hasConcept C126322002 @default.
- W1989751695 hasConcept C141071460 @default.
- W1989751695 hasConcept C143998085 @default.
- W1989751695 hasConcept C2776694085 @default.
- W1989751695 hasConcept C2776907518 @default.
- W1989751695 hasConcept C2778239845 @default.
- W1989751695 hasConcept C2780456651 @default.
- W1989751695 hasConcept C2780873365 @default.
- W1989751695 hasConcept C2781413609 @default.
- W1989751695 hasConcept C29730261 @default.
- W1989751695 hasConcept C31760486 @default.
- W1989751695 hasConcept C43376680 @default.
- W1989751695 hasConcept C71924100 @default.
- W1989751695 hasConcept C90924648 @default.
- W1989751695 hasConceptScore W1989751695C121608353 @default.
- W1989751695 hasConceptScore W1989751695C126322002 @default.
- W1989751695 hasConceptScore W1989751695C141071460 @default.
- W1989751695 hasConceptScore W1989751695C143998085 @default.
- W1989751695 hasConceptScore W1989751695C2776694085 @default.
- W1989751695 hasConceptScore W1989751695C2776907518 @default.
- W1989751695 hasConceptScore W1989751695C2778239845 @default.
- W1989751695 hasConceptScore W1989751695C2780456651 @default.
- W1989751695 hasConceptScore W1989751695C2780873365 @default.
- W1989751695 hasConceptScore W1989751695C2781413609 @default.
- W1989751695 hasConceptScore W1989751695C29730261 @default.
- W1989751695 hasConceptScore W1989751695C31760486 @default.
- W1989751695 hasConceptScore W1989751695C43376680 @default.
- W1989751695 hasConceptScore W1989751695C71924100 @default.
- W1989751695 hasConceptScore W1989751695C90924648 @default.
- W1989751695 hasIssue "1" @default.
- W1989751695 hasLocation W19897516951 @default.
- W1989751695 hasLocation W19897516952 @default.
- W1989751695 hasOpenAccess W1989751695 @default.
- W1989751695 hasPrimaryLocation W19897516951 @default.
- W1989751695 hasRelatedWork W1531122021 @default.
- W1989751695 hasRelatedWork W2039697777 @default.
- W1989751695 hasRelatedWork W2043141978 @default.
- W1989751695 hasRelatedWork W2047376960 @default.
- W1989751695 hasRelatedWork W2052181765 @default.
- W1989751695 hasRelatedWork W2100029565 @default.
- W1989751695 hasRelatedWork W2132039541 @default.
- W1989751695 hasRelatedWork W2175496181 @default.
- W1989751695 hasRelatedWork W2388348438 @default.
- W1989751695 hasRelatedWork W2397882301 @default.
- W1989751695 hasVolume "53" @default.
- W1989751695 isParatext "false" @default.
- W1989751695 isRetracted "false" @default.
- W1989751695 magId "1989751695" @default.
- W1989751695 workType "article" @default.